These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 210428)

  • 21. Effect of litholytic bile acids on cholesterol absorption in gallstone patients.
    LaRusso NF; Thistle JL
    Gastroenterology; 1983 Feb; 84(2):265-71. PubMed ID: 6848406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of vesicular lithiasis with chenic acid].
    Van Waes L; de Weert M; Schurgers M; Barbier F; Demeulenaere L
    Med Chir Dig; 1975; 4 Suppl 1():19-22. PubMed ID: 1230590
    [No Abstract]   [Full Text] [Related]  

  • 23. [Dyslipidemic patients with coronary cardiopathy. Effect of different doses of OMEGA-3 fatty acids on serum lipids and lipoproteins].
    Arteaga A; Villanueva CL; Skorin C; Guasch V; Solís de Ovando F; Velasco N; Acosta AM; Leighton F
    Rev Med Chil; 1993 Jun; 121(6):618-25. PubMed ID: 8278696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholesterol kinetics in patients with cholesterol gallstones before and during chenodeoxycholic acid treatment.
    Pedersen L; Arnfred T; Thaysen EH
    Scand J Gastroenterol; 1974 Nov; 9(8):787-91. PubMed ID: 4610716
    [No Abstract]   [Full Text] [Related]  

  • 25. Changes in the concentration and composition of lipids and lipoproteins in primary hyperlipoproteinemia during treatment with bezafibrate.
    Hutt V; Wechsler JG; Klör HU; Ditschuneit H
    Arzneimittelforschung; 1983; 33(8):1185-90. PubMed ID: 6685498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C; Olsson AG
    Int J Clin Pract Suppl; 2002 Jul; (130):27-32. PubMed ID: 12296606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma lipid profile in gallstone patients from North India.
    Saraya A; Irshad M; Gandhi BM; Tandon RK
    Trop Gastroenterol; 1995; 16(4):16-21. PubMed ID: 8854950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of ciprofibrate on the endothelial dysfunction of patients with combined dyslipidemia].
    Kovács I; Tarján J; Császár A
    Orv Hetil; 2001 Apr; 142(15):775-9. PubMed ID: 11367862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of tibric acid (CP-18.254) on plasma lipids in patients with primary endogenous hyperlipoproteinemia].
    Lisch HJ; Sailer S; Braunsteiner H
    Arzneimittelforschung; 1977; 27(10):2017-20. PubMed ID: 579116
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inheritance of endogenous hypertriglyceridaemia type IIB or IV.
    Nikkilä EA; Aro A
    Postgrad Med J; 1975; 51(8):suppl 32-6. PubMed ID: 215979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chenodeoxycholic acid for hypertriglyceridaemia.
    Bateson MC
    Lancet; 1976 Oct; 2(7992):962-3. PubMed ID: 62188
    [No Abstract]   [Full Text] [Related]  

  • 32. Gemfibrozil in dyslipidaemia.
    Kundu SC; Roxy S; Batabyal SK
    J Assoc Physicians India; 1990 Feb; 38(2):156-9. PubMed ID: 2199426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Study of lipid metabolic coefficient K2 in patients with hyperlipoproteinemia type IV before and after reduction of triglyceride level by adapted diet therapy].
    Drouin P; Lambert D; Mejean L; Pointel JP; Debry G
    Nutr Metab; 1979; 23(5):416-28. PubMed ID: 225702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Minimum effective dose of chenic acid for gallstone patients: reduction with bedtime administration and low cholesterol diet.
    Maudgal DP; Kupfer RM; Northfield TC
    Gut; 1982 Apr; 23(4):280-4. PubMed ID: 7076005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypertriglyceridaemia and chenodeoxycholic acid.
    Marcolongo R; Debolini A
    Adv Exp Med Biol; 1977; 76A():557-62. PubMed ID: 855730
    [No Abstract]   [Full Text] [Related]  

  • 36. [Results and prospects of therapy of type IV dyslipidemia with chenic acid].
    Camarri E; Marcolongo R; Marini G; Zaccherotti L
    Minerva Med; 1978 May; 69(23):1561-74. PubMed ID: 210428
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The hypotriglyceridemic effect of chenodeoxycholic acid in type IV hyperlipemia.
    Camarri E; Marcolongo R; Zaccherotti L; Marini G
    Biomedicine; 1978 Oct; 29(6):193-8. PubMed ID: 216433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypotriglyceridemic effect of chenodeoxycholic acid after a short time of administration.
    Camarri E; Marcolongo R; Fici F
    Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):527-8. PubMed ID: 365797
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of chenodeoxycholic acid on serum triglycerides in patients with primary hypertriglyceridemia.
    Camarri E; Fici F; Marcolongo R
    Int J Clin Pharmacol Biopharm; 1978 Nov; 16(11):523-6. PubMed ID: 365796
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dyslipidemias in patients with diabetes mellitus: classification and risks and benefits of therapy.
    Oki JC
    Pharmacotherapy; 1995; 15(3):317-37. PubMed ID: 7667166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.